Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sophie Piperno-Neumann

Showing results (81-90 of 148) with videos related to

Pageof 15
Sort By:
International Journal of Cancer|October 6, 2021
Rare bone sarcomas: A retrospective analysis of 145 adult patients from the French Sarcoma GroupPascaline Boudou-Rouquette, Elodie Martin, Emmanuelle Kempf, et al.
Molecular Cancer Therapeutics|February 8, 2020
Genomic Profiling of Metastatic Uveal Melanoma and Clinical Results of a Phase I Study of the Protein Kinase C Inhibitor AEB071Sophie Piperno-Neumann, James Larkin, Richard D Carvajal, et al.
The New England Journal of Medicine|September 4, 2024
Doxorubicin-Trabectedin with Trabectedin Maintenance in LeiomyosarcomaPatricia Pautier, Antoine Italiano, Sophie Piperno-Neumann, et al.
The Lancet. Oncology|July 14, 2022
Doxorubicin alone versus doxorubicin with trabectedin followed by trabectedin alone as first-line therapy for metastatic or unresectable leiomyosarcoma (LMS-04): a randomised, multicentre, open-label phase 3 trialPatricia Pautier, Antoine Italiano, Sophie Piperno-Neumann, et al.
British Journal of Cancer|July 13, 2023
Immunohistochemical characterisation of the immune landscape in primary uveal melanoma and liver metastasesPascale Mariani, Nouritza Torossian, Steven van Laere, et al.
Annals of Surgical Oncology|January 29, 2020
Surgical Margins and Adjuvant Therapies in Malignant Phyllodes Tumors of the Breast: A Multicenter Retrospective StudyMathias Neron, Christophe Sajous, Simon Thezenas, et al.
Annals of Surgical Oncology|November 28, 2019
Impact of Metastasis Surgery and Alkylating-Agent-Based Chemotherapy on Outcomes of Metastatic Malignant Phyllodes Tumors: A Multicenter Retrospective StudyMathias Neron, Christophe Sajous, Simon Thezenas, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 28, 2019
Genomic and transcriptomic comparison of post-radiation versus sporadic sarcomasTom Lesluyes, Jessica Baud, Gaëlle Pérot, et al.
The Lancet. Oncology|March 22, 2015
Trabectedin in combination with doxorubicin for first-line treatment of advanced uterine or soft-tissue leiomyosarcoma (LMS-02): a non-randomised, multicentre, phase 2 trialPatricia Pautier, Anne Floquet, Christine Chevreau, et al.
Cancers|June 1, 2019
PARP Inhibition Increases the Response to Chemotherapy in Uveal MelanomaLeanne de Koning, Didier Decaudin, Rania El Botty, et al.
Pageof 15

Showing results (81-90 of 148) with videos related to

Sort By:
Pageof 15
International Journal of Cancer|October 6, 2021
Rare bone sarcomas: A retrospective analysis of 145 adult patients from the French Sarcoma GroupPascaline Boudou-Rouquette, Elodie Martin, Emmanuelle Kempf, et al.
Molecular Cancer Therapeutics|February 8, 2020
Genomic Profiling of Metastatic Uveal Melanoma and Clinical Results of a Phase I Study of the Protein Kinase C Inhibitor AEB071Sophie Piperno-Neumann, James Larkin, Richard D Carvajal, et al.
The New England Journal of Medicine|September 4, 2024
Doxorubicin-Trabectedin with Trabectedin Maintenance in LeiomyosarcomaPatricia Pautier, Antoine Italiano, Sophie Piperno-Neumann, et al.
The Lancet. Oncology|July 14, 2022
Doxorubicin alone versus doxorubicin with trabectedin followed by trabectedin alone as first-line therapy for metastatic or unresectable leiomyosarcoma (LMS-04): a randomised, multicentre, open-label phase 3 trialPatricia Pautier, Antoine Italiano, Sophie Piperno-Neumann, et al.
British Journal of Cancer|July 13, 2023
Immunohistochemical characterisation of the immune landscape in primary uveal melanoma and liver metastasesPascale Mariani, Nouritza Torossian, Steven van Laere, et al.
Annals of Surgical Oncology|January 29, 2020
Surgical Margins and Adjuvant Therapies in Malignant Phyllodes Tumors of the Breast: A Multicenter Retrospective StudyMathias Neron, Christophe Sajous, Simon Thezenas, et al.
Annals of Surgical Oncology|November 28, 2019
Impact of Metastasis Surgery and Alkylating-Agent-Based Chemotherapy on Outcomes of Metastatic Malignant Phyllodes Tumors: A Multicenter Retrospective StudyMathias Neron, Christophe Sajous, Simon Thezenas, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 28, 2019
Genomic and transcriptomic comparison of post-radiation versus sporadic sarcomasTom Lesluyes, Jessica Baud, Gaëlle Pérot, et al.
The Lancet. Oncology|March 22, 2015
Trabectedin in combination with doxorubicin for first-line treatment of advanced uterine or soft-tissue leiomyosarcoma (LMS-02): a non-randomised, multicentre, phase 2 trialPatricia Pautier, Anne Floquet, Christine Chevreau, et al.
Cancers|June 1, 2019
PARP Inhibition Increases the Response to Chemotherapy in Uveal MelanomaLeanne de Koning, Didier Decaudin, Rania El Botty, et al.
Pageof 15